Pfizer, Samsung, Microsoft, WIPO: Intellectual Property
News | 20 July 2012
Pfizer Inc. (PFE) won a ruling that blocks generic versions of its drug Lyrica until 2018. U.S. District Judge Gregory M. Sleet ruled yesterday that Teva Pharmaceutical Industries Ltd. (TEVA) and other generic-drug makers infringed some claims of ...
Click on the link to read the full article at Bloomberg
(This link will open in a new window)
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
